| Pharmaceuticals Industry | Healthcare Sector | Raj Sutaria CEO | EXPM Exchange | 460588106 CUSIP |
| US Country | 670 Employees | - Last Dividend | 19 Nov 1997 Last Split | 12 Feb 1993 IPO Date |
Interpharm Holdings, Inc., established in 1984, distinguishes itself in the pharmaceutical industry by developing, manufacturing, and marketing both generic prescription strength and over-the-counter medications. With its headquarters in Hauppauge, New York, the company has carved a niche for itself by supplying high-quality pharmaceuticals to a variety of clients, including major retailers, wholesalers, managed care organizations, and national distributors. This strategic positioning enables Interpharm Holdings, Inc. to play a significant role in the healthcare supply chain, ensuring that essential medications are accessible to a wide patient base.
Interpharm Holdings, Inc. specializes in the formulation and production of generic medications that are equivalent in dosage, strength, route of administration, quality, performance characteristics, and intended use to their brand-name counterparts. This segment of their offerings aims to provide more affordable medication options to individuals and healthcare providers, thereby playing a crucial role in managing healthcare costs effectively.
Beyond prescription medications, Interpharm Holdings, Inc. offers a wide array of over-the-counter (OTC) products. These include medicines for a variety of common conditions and symptoms, such as pain relief, cold and allergy, gastrointestinal health, and more. OTC products from Interpharm are designed to be safe and effective for self-medication, allowing consumers to manage their health conveniently and autonomously.